TWM
ABBV icon

Titus Wealth Management’s AbbVie ABBV Stock Holding History

Titus Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$426K Buy
2,778
+141
+5% +$21.5K 0.21% 79
2022
Q1 		$427K Buy
2,637
+168
+7% +$24.4K 0.19% 87
2021
Q4 		$334K Sell
2,469
-135
-5% -$15.9K 0.15% 107
2021
Q3 		$282K Buy
+2,604
New +$298K 0.15% 117

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Titus Wealth Management's ABBV Position: Q2 2022 in Review

Titus Wealth Management increased its AbbVie (ABBV) stake by 5.3% in Q2 2022, buying an estimated $21.5K and bringing the position to 2,778 shares worth $426K. The position accounts for 0.21% of the portfolio, ranked #79.

Titus Wealth Management first reported a position in ABBV in Q3 2021 and has held it in 4 quarters since. The position peaked at $427K in Q1 2022. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Titus Wealth Management held 2,778 shares of AbbVie worth $426K as of Q2 2022.
  • Titus Wealth Management bought 141 AbbVie shares in Q2 2022, an estimated $21.5K.
  • AbbVie made up 0.21% of Titus Wealth Management's portfolio in Q2 2022, its #79 holding.
  • Titus Wealth Management first reported a position in AbbVie in Q3 2021 and has held it in 4 quarters since.
  • Titus Wealth Management's AbbVie position peaked at $427K in Q1 2022.
  • 3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Titus Wealth Management's 13F filing for Q2 2022, filed 9 Nov 2022.